285 results
6-K
EX-99.2
THTX
Theratechnologies Inc.
15 Apr 24
Notice of Annual Meeting of Shareholders
9:31am
. The group was responsible for regulatory strategy and registration of products globally. His tasks included providing guidance on the worldwide … . The group was responsible for regulatory strategy and registration of products globally.
Prior to joining Pfizer, he was at Merck and Co. Inc
6-K
EX-99.3
THTX
Theratechnologies Inc.
10 Apr 24
Interim Consolidated Financial Statements
8:30am
certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (“DC&P”) and internal control over financial
6-K
EX-99.4
THTX
Theratechnologies Inc.
10 Apr 24
Interim Consolidated Financial Statements
8:30am
other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (“DC&P”) and internal control over
6-K
EX-99.2
THTX
Theratechnologies Inc.
10 Apr 24
Interim Consolidated Financial Statements
8:30am
, Liquidity and Capital Resources
Going Concern Uncertainty
As part of the preparation of these Interim Financial Statements, management is responsible
6-K
EX-99.1
THTX
Theratechnologies Inc.
10 Apr 24
Interim Consolidated Financial Statements
8:30am
is responsible for identifying any event or situation that may cast doubt on the Company’s ability to continue as a going concern. Substantial doubt
6-K
EX-99.1
fg56 0w32xek3c4hi
10 Apr 24
Theratechnologies Reports Financial Results
8:16am
6-K
EX-99.1
qed 9awws
22 Mar 24
Theratechnologies Appoints Jordan Zwick to its Board of Directors
1:37pm